Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

Content from other channels on our network

Innovating chemical dosing & dilution in aged care

Unify risk and compliance to protect patients.

Australian health care's burnout prescription

"Fake podiatrist" jailed after hundreds of consultations with vulnerable patients

Unlocking the potential of our nursing workforce

Valves, data centres and the invisible infrastructure of Australian industry

NVIDIA technology aims to give factories an AI brain

New Energy Transport secures funding to accelerate electric road freight

DroneShield marks global manufacturing milestone in Europe

Siemens expands Queensland manufacturing facility

WA dog food manufacturer seals SE Asia export deal

Food safety recalls in NZ: the 2025 report

From raw to rare sugar: low-cal sweetener under development

Upcycling cauliflower waste into protein ingredients for future food

Lolly factory celebrates 50 years with new technology installed